Sell alert! Why this expert is calling time on Westpac and CBA shares

A leading expert forecasts growing headwinds for Westpac and CBA shares.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Westpac Banking Corp (ASX: WBC) and Commonwealth Bank of Australia (ASX: CBA) shares have both underperformed the 2.3% 12-month gain posted by the S&P/ASX 200 Index (ASX: XJO) earlier this week.

In fact, both of the big four ASX 200 bank stocks are well into the red since this time last year.

With CBA shares recently trading for $157.08 apiece, Australia's biggest bank stock is down 7.8% in 12 months.

Westpac shares have fared even worse, recently down 11.3% for the year at $33.95 each.

Now we shouldn't leave out the fully franked dividends both banks have paid out over the full year. CBA shares trade on a fully franked dividend yield of 3.2%, while Westpac shares trade on a fully franked dividend yield of 4.5%.

Though even with these dividends in mind, the accumulated value of both ASX 200 bank stocks has gone backwards over the past year.

And looking ahead, Red Leaf Securities' John Athanasiou expects they'll both continue to struggle (courtesy of The Bull).

Here's why.

Time to sell written on a clock.

Image source: Getty Images

Time to exit CBA shares?

"CBA shares deserve to trade at a premium given its dominant retail franchise, strong technology platform, solid deposit base and consistent execution," Athanasiou said.

Summarising his sell recommendation on CBA shares, he concluded:

However, Australian banking remains a mature industry, with intense competition across mortgages and deposits limiting the potential for outsized earnings growth. At a premium valuation, investors are paying a higher price for quality, leaving little room for disappointment.

After a substantial re-rating, investors may be better served taking some profits and reallocating capital towards businesses offering stronger growth at more reasonable valuations.

Which brings us to…

Westpac shares could be facing competitive headwinds

Athanasiou also issued a sell recommendation on Westpac shares.

"The bank remains well capitalised and continues to generate solid earnings, but the operating environment is becoming increasingly competitive," he said. "Mortgage pricing is aggressive, deposit competition remains intense, and the scope for sustained margin expansion appears limited."

And Westpac's 4.5% dividend yield isn't enough to tip the scales for Athanasiou.

He noted:

Westpac's dividend remains attractive, but investors should also consider opportunity cost.

We believe there are more compelling opportunities on the ASX, which offer stronger structural growth or more attractive valuations.

Another expert is bearish on CBA shares

Athanasiou wasn't the only analyst to advise selling CBA shares this week.

He was joined by Alto Capital's Tony Locantro.

"The CBA remains Australia's leading banking franchise and delivered another strong result in full year 2026," Locantro said.

Commenting on those strong results, he said:

Cash net profit after tax of $10.982 billion was up 7% on the prior corresponding period. The full-year dividend of $5.05 a share, fully franked, was up 4%. Strong lending, deposit growth and a robust capital position continue to demonstrate the quality of the business.

As for his sell recommendation, Locantro concluded:

However, operating expenses and loan impairment expenses increased.

The CBA continues to trade at a substantial valuation premium to domestic banking peers. Although the underlying business remains strong, the premium valuation leaves little room for disappointment and may potentially constrain prospective returns.

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Teen standing in a city street smiling and throwing sparkling gold glitter into the air.
Broker Notes

9 ASX shares just upgraded by the experts

Several ASX 200 gold miners are in the mix.

Read more »

A guys points his fingers down.
Broker Notes

6 ASX shares downgraded by brokers this week

Brokers cut their ratings on Elders, Charter Hall Retail REIT, Sims, and other stocks this week. 

Read more »

A man clenches his fists in excitement as gold coins fall from the sky.
Broker Notes

Morgans says these ASX shares could return 48% to 95%

The broker is recommending these shares to investors this week.

Read more »

Farmer holding grains in his hands.
Broker Notes

Why this broker thinks GrainCorp shares are a buy after yesterday's fall

This broker is expecting a rebound.

Read more »

Doctor with stethoscope holding a tablet and smiling.
Healthcare Shares

ASX healthcare shares are 39% higher since June. Are you missing out?

Healthcare stocks endured a long slump before the sector pivoted three months ago.

Read more »

Six smiling office colleagues stand in a row and look at the camera.
Broker Notes

9 ASX 200 shares earning strengthened buy ratings this week

Brokers retained a positive view on Santos, Goodman, AMP, Telstra, and other shares this week. 

Read more »

A middle-aged man working from home looks at his mobile phone with a laptop open on the table in front of him.
Broker Notes

Buy, hold, sell: Select Harvests, Seek, SKS Technologies shares

Experts reveal their ratings on 3 ASX shares in the agriculture, communications, and tech segments. 

Read more »

A young man working from home sits at his home office desk holding a cup of tea and looking out the window.
Broker Notes

Buy, hold, sell: Generation Development, Fletcher Building, Saluda Medical shares

We review 3 fresh buy, hold, and sell calls from expert market analysts. 

Read more »